BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28154932)

  • 1. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study.
    You C; Lamba N; Lasave AF; Ma L; Diaz MH; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1221-1228. PubMed ID: 28154932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab as an Adjuvant Rescue Treatment for Ocular Cicatricial Pemphigoid.
    Bevans SL; Parker J; Ivey JM; Pavlidakey P; Sami N
    Cornea; 2021 Nov; 40(11):1440-1444. PubMed ID: 33591038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
    Foster CS; Chang PY; Ahmed AR
    Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy.
    Ma L; You C; Hernandez M; Maleki A; Lasave A; Schmidt A; Stephenson A; Zhao T; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2019; 27(4):636-642. PubMed ID: 29517945
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
    Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
    Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission of ocular cicatricial pemphigoid off immunomodulatory therapy.
    You C; Ma L; Anesi SD; Stephen Foster C
    Eur J Ophthalmol; 2018 Mar; 28(2):157-162. PubMed ID: 29077176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
    Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
    Front Immunol; 2018; 9():248. PubMed ID: 29520266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
    Szabó E; Palos M; Skalická P
    Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab preserves vision in ocular mucous membrane pemphigoid.
    Rübsam A; Stefaniak R; Worm M; Pleyer U
    Expert Opin Biol Ther; 2015 Jul; 15(7):927-33. PubMed ID: 25966960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate therapy for ocular cicatricial pemphigoid.
    McCluskey P; Chang JH; Singh R; Wakefield D
    Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
    Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
    Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conjunctival-sparing surgical technique for lower eyelid cicatricial entropion repair in ocular cicatricial pemphigoid.
    Choung H; Reshef ER; Tanking T; Freitag SK
    Orbit; 2020 Feb; 39(1):23-30. PubMed ID: 30732510
    [No Abstract]   [Full Text] [Related]  

  • 14. Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab.
    Baniel A; Oestreicher-Kedem Y; Peled A; Bar-Ilan E; Geller S; Sprecher E; Baum S
    Clin Exp Dermatol; 2021 Jul; 46(5):915-919. PubMed ID: 33811681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopy in Patients With Ocular Cicatricial Pemphigoid.
    Ebrahimiadib N; Hernandez M; Modjtahedi BS; Roohipoor CR; Foster CS
    Cornea; 2018 Apr; 37(4):436-441. PubMed ID: 29341971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Cicatricial Pemphigoid With IgM-Positive Biopsy.
    Philip AM; Stephenson A; Al-Dabbagh A; Ramezani K; Fernandez-Santos CC; Foster CS
    Cornea; 2023 Dec; 42(12):1503-1505. PubMed ID: 36728301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repository Corticotropin Injection as an Alternative Treatment for Refractory Ocular Mucous Membrane Pemphigoid.
    Sharon Y; Anesi SD; Martinez CE; Huang AJW; Foster CS; Chu DS
    Cornea; 2022 Jan; 41(1):45-51. PubMed ID: 34050065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
    Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
    Front Immunol; 2022; 13():915205. PubMed ID: 35844526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Approach to Ocular Cicatricial Pemphigoid.
    Çiftçi MD; Korkmaz İ; Palamar M; Yaman B; Eğrilmez S; Yağcı A; Akalın T; Barut Selver Ö
    Turk J Ophthalmol; 2023 Apr; 53(2):79-84. PubMed ID: 37089009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review.
    Fremont F; Pelissier-Suarez C; Fournié P; Porterie M; Thevenin A; Astudillo L; Paricaud K; Gualino V; Soler V; Pugnet G
    Cornea; 2019 Nov; 38(11):1406-1411. PubMed ID: 31356420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.